Virtual Key Opinion Leader Event to Discuss NS002 for the Treatment of Anaphylaxis lsc-webmaster / June 10, 2026
Nasus Pharma to Present Topline Analysis from NS002 Intranasal Epinephrine Powder Phase 2 Single and Repeat Dose Clinical Study lsc-webmaster / March 16, 2026
